← Catalog
Research Material · Blends
IPA / CJC
5/5 mg · per vial
Purity: >99%
COA status: PublishedDocumentation status shown clearlyU.S.-based supportAccount-protected ordering
$80.00
Laboratory research use only
No dosing, clinical-use, safety, or efficacy guidance is provided.
Product details
A research blend combining ipamorelin with a CJC-series GHRH analog.
Used to study simultaneous ghrelin-receptor and GHRH-receptor pathway activation in controlled models.
Research areas: Receptor crosstalk · Endocrine signaling · Combination studies
Specifications
- Size
- 5/5 mg
- Form
- Lyophilized powder (not reconstituted)
- Category
- Blends
- Other names
- Ipamorelin + CJC-1295 blend
- Purity
- >99%
- Documentation
- COA published · Lot PPH-CJI10-20260831-01
- Intended use
- Laboratory research only